Form 4: 180 Life Sciences Corp. CEO Gains Voting Control Over 43,166 Shares

CEO Blair Jordan gains voting power over 43,166 shares of 180 Life Sciences Corp. common stock through a voting agreement with Dr. James Woody.

Summary

• On February 5, 2025, Blair Jordan, CEO of 180 Life Sciences Corp., entered into a voting agreement with Dr. James Woody.
• Under the agreement, Dr. Woody will vote 43,166 shares of 180 Life Sciences Corp.'s common stock as recommended by the Board of Directors.
• This voting arrangement is valid until February 5, 2026, or until Dr. Woody sells all shares, or the Issuer terminates the Voting Agreement.
• To enforce the agreement, Dr. Woody granted Mr. Jordan an irrevocable voting proxy for the 43,166 shares.
• Mr. Jordan may be deemed to beneficially own these shares due to the voting proxy, but he has no dispositive control or pecuniary interest beyond the voting rights.

Sentiment

Score: 6

Explanation: The document is neutral, simply reporting a change in beneficial ownership due to a voting agreement. It doesn't inherently suggest positive or negative outcomes.

Positives

• The voting agreement strengthens the CEO's influence on company decisions.

Risks

• The voting agreement could concentrate power in the hands of the CEO, potentially limiting shareholder influence.

Future Outlook

The voting agreement is in place until February 5, 2026, unless Dr. Woody sells all shares or the Issuer terminates the agreement.

Industry Context

Voting agreements are common in corporate governance to consolidate voting power and influence company decisions.

Stakeholder Impact

• Shareholders may be impacted by the concentration of voting power in the CEO's hands.

Key Dates

Keywords

Voting Agreement, Beneficial Ownership, Proxy, Shares, Jordan, Woody, ATNF, 180 Life Sciences Corp.